BDTX (STOCKS)
Black Diamond Therapeutics, Inc. Common Stock
$2.001300
-0.098700 (-4.70%)
Prev close: $2.100000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Mark A. Velleca
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $140.07M
- Employees
- 54
- P/E (TTM)
- -2.82
- P/B (TTM)
- 1.26
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $9.35M |
| Operating Expenses | $51.90M |
| Research and Development | $28.13M |
| Other Operating Expenses | $23.78M |
| Operating Income/Loss | -$51.90M |
| Income/Loss From Continuing Operations After Tax | -$42.56M |
| Income/Loss From Continuing Operations Before Tax | -$27.44M |
| Net Income/Loss | -$42.56M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$42.56M |
| Net Income/Loss Available To Common Stockholders, Basic | -$42.56M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.75 |
| Diluted Earnings Per Share | -$0.74 |
| Basic Average Shares | 171,598,155 |
| Diluted Average Shares | 171,612,033 |
| Assets | $125.03M |
| Current Assets | $115.39M |
| Noncurrent Assets | $9.64M |
| Fixed Assets | $310.00K |
| Other Non-current Assets | $9.33M |
| Liabilities | $28.94M |
| Current Liabilities | $15.84M |
| Accounts Payable | $1.40M |
| Wages | $1.81M |
| Other Current Liabilities | $12.63M |
| Noncurrent Liabilities | $13.10M |
| Equity | $96.09M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $96.09M |
| Liabilities And Equity | $125.03M |
| Net Cash Flow From Operating Activities | -$32.84M |
| Net Cash Flow From Operating Activities, Continuing | -$32.84M |
| Net Cash Flow From Investing Activities | $22.08M |
| Net Cash Flow From Investing Activities, Continuing | $22.08M |
| Net Cash Flow From Financing Activities | -$30.00K |
| Net Cash Flow From Financing Activities, Continuing | -$30.00K |
| Net Cash Flow | -$10.79M |
| Net Cash Flow, Continuing | -$10.79M |
| Comprehensive Income/Loss | -$42.46M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$42.60M |
| Other Comprehensive Income/Loss | -$33.43M |